Katherine B Santosa1, Hsou-Mei Hu1, Chad M Brummett2, Margaret A Olsen3, Michael J Englesbe4, Eva A Williams5, Jennifer F Waljee6. 1. Section of Plastic Surgery, Department of Surgery, University of Michigan Health System, Ann Arbor, MI. 2. Division of Pain Medicine, Department of Anesthesia, University of Michigan Health System, Ann Arbor, MI. 3. Division of Infectious Diseases, Department of Medicine, and Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO. 4. Section of Transplantation, Department of Surgery, University of Michigan Health System, Ann Arbor, MI. 5. Miller School of Medicine, University of Miami, Coral Gables, FL. 6. Section of Plastic Surgery, Department of Surgery, University of Michigan Health System, Ann Arbor, MI. Electronic address: filip@med.umich.edu.
Abstract
BACKGROUND: Although new persistent opioid use and high-risk prescribing have been recognized as important postoperative complications among younger patients (18-64 years of age), little is known about the incidence for postoperative opioid use among older patients (>65 years of age). METHODS: We analyzed a 20% national sample of Medicare Part D claims among beneficiaries >65 years of age who underwent a major or minor surgical procedure between January 1, 2009, and June 30, 2015. We identified patients without an opioid prescription fill in the year before surgery and examined their perioperative and 6-month postoperative opioid prescription fills to examine the incidence of new persistent opioid use and high-risk prescribing. RESULTS: We identified 81,839 opioid naïve patients who underwent surgery and filled an opioid prescription perioperatively. Overall, 9.8% developed new persistent opioid use. Risk factors for new persistent opioid use included major surgery (adjusted odds ratio [aOR] 1.24, 95% confidence interval [CI] 1.17-1.31), more comorbid conditions (aOR 1.71, 95% CI 1.58-1.84), mood disorders (aOR 1.16, 95% CI 1.09-1.24), suicide or self-harm (aOR 1.60, 95% CI 1.05-2.44), substance abuse disorders (aOR 1.38, 95% CI 1.20-1.59), filling an opioid prescription before surgery (aOR 1.67, 95% CI 1.58-1.77), higher amounts of opioids filled (aOR 1.44, 95% CI 1.37-1.52), black race (aOR 1.23, 95% CI 1.12-1.36), and Medicaid eligibility (aOR 1.45, 95% CI 1.35-1.55). CONCLUSION: About 10% of Medicare beneficiaries who were previously opioid naïve continue to fill opioids past 3 months after surgery. In addition to comorbidities and mental health conditions, new persistent opioid use is associated with surgery type, preoperative opioid fill, high-risk prescribing practices, and sociodemographic factors.
BACKGROUND: Although new persistent opioid use and high-risk prescribing have been recognized as important postoperative complications among younger patients (18-64 years of age), little is known about the incidence for postoperative opioid use among older patients (>65 years of age). METHODS: We analyzed a 20% national sample of Medicare Part D claims among beneficiaries >65 years of age who underwent a major or minor surgical procedure between January 1, 2009, and June 30, 2015. We identified patients without an opioid prescription fill in the year before surgery and examined their perioperative and 6-month postoperative opioid prescription fills to examine the incidence of new persistent opioid use and high-risk prescribing. RESULTS: We identified 81,839 opioid naïve patients who underwent surgery and filled an opioid prescription perioperatively. Overall, 9.8% developed new persistent opioid use. Risk factors for new persistent opioid use included major surgery (adjusted odds ratio [aOR] 1.24, 95% confidence interval [CI] 1.17-1.31), more comorbid conditions (aOR 1.71, 95% CI 1.58-1.84), mood disorders (aOR 1.16, 95% CI 1.09-1.24), suicide or self-harm (aOR 1.60, 95% CI 1.05-2.44), substance abuse disorders (aOR 1.38, 95% CI 1.20-1.59), filling an opioid prescription before surgery (aOR 1.67, 95% CI 1.58-1.77), higher amounts of opioids filled (aOR 1.44, 95% CI 1.37-1.52), black race (aOR 1.23, 95% CI 1.12-1.36), and Medicaid eligibility (aOR 1.45, 95% CI 1.35-1.55). CONCLUSION: About 10% of Medicare beneficiaries who were previously opioid naïve continue to fill opioids past 3 months after surgery. In addition to comorbidities and mental health conditions, new persistent opioid use is associated with surgery type, preoperative opioid fill, high-risk prescribing practices, and sociodemographic factors.
Authors: Chad M Brummett; Jennifer F Waljee; Jenna Goesling; Stephanie Moser; Paul Lin; Michael J Englesbe; Amy S B Bohnert; Sachin Kheterpal; Brahmajee K Nallamothu Journal: JAMA Surg Date: 2017-06-21 Impact factor: 14.766
Authors: Jay Soong-Jin Lee; Hsou Mei Hu; Anthony L Edelman; Chad M Brummett; Michael J Englesbe; Jennifer F Waljee; Jeffrey B Smerage; Jennifer J Griggs; Hari Nathan; Jacqueline S Jeruss; Lesly A Dossett Journal: J Clin Oncol Date: 2017-10-19 Impact factor: 44.544
Authors: Ruchir N Karmali; Asheley C Skinner; Justin G Trogdon; Morris Weinberger; Steven Z George; Kristen Hassmiller Lich Journal: Med Care Date: 2020-05 Impact factor: 2.983
Authors: Katherine B Santosa; Christine S Wang; Hsou-Mei Hu; Chad M Brummett; Michael J Englesbe; Jennifer F Waljee Journal: Am J Surg Date: 2020-06-19 Impact factor: 2.565
Authors: Mark A Lockett; Ralph C Ward; Jenna L McCauley; David J Taber; Mulugeta Gebregziabher; Robert A Cina; William T Basco; Patrick D Mauldin; Sarah J Ball Journal: Surg Open Sci Date: 2022-05-20
Authors: Deborah S Keller; Brooke C Kenney; Calista M Harbaugh; Jennifer F Waljee; Chad M Brummett Journal: Surgery Date: 2020-12-04 Impact factor: 3.982
Authors: Ryan Howard; Vidhya Gunaseelan; Chad Brummett; Jennifer Waljee; Michael Englesbe; Dana Telem Journal: Ann Surg Date: 2020-10-15 Impact factor: 13.787
Authors: Mary Falcone; Chongliang Luo; Justin E Bekelman; Caryn Lerman; Yong Chen; David Birtwell; Martin Cheatle; Rui Duan; Peter E Gabriel; Lifang He; Emily M Ko; Heinz-Josef Lenz; Nebojsa Mirkovic; Danielle L Mowery; E Andrew Ochroch; E Carter Paulson; Emily Schriver; Robert A Schnoll Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-08-28 Impact factor: 4.254